PerpEquities

Equity

DexCom, Inc. (DXCM) perpetual futures

DexCom, Inc. is a US medical technology company that develops and markets continuous glucose monitoring (CGM) systems, including Dexcom G6, Dexcom ONE, Dexcom Share and the Dexcom Real-Time API, for people with diabetes and healthcare practitioners.

NASDAQ closed
Open in terminal

Price chart

Interactive TradingView chart

TradingView symbol NASDAQ:DXCM

Loads TradingView's third-party widget (about 1 MB) on demand.

Auto: underlying reference priceOpen in TradingView

Trading data

Perpetual market activity

0/0 live markets
Venues
0
Live markets
0/0
24h volume
-
Open interest
-
Best liquidity
-
Tightest spread
-
Highest volume
-
Settlement mix
-
Perp/spot vol.
-
OI / float
-
Spot performance
1D-0.97%
5D-2.49%
1M-2.99%
6M+39.15%
YTD+30.51%
1Y+30.33%

Venue matrix

0 markets

Some venue links are sponsored. We may receive a commission, and eligible users may occasionally receive trading-fee discounts, at no additional cost to you.

Trade
Best venues for this underlying

Best liquidity

-
No live data-

Tightest spread

-
No live data-

Highest volume

-
No live data-

Company data

Company fundamentals

Updated 2h ago
Market cap
$32.7B
Updated 2h ago
Revenue
$5B
Trailing 12 months
Revenue growth
+12%
Next fiscal year
Profit margin
+20.1%
P/E
33.4
Peer P/E 33.1
Free cash flow
$1.4B
Trailing 12 months
More metrics
Net income
$999.7M
Trailing 12 months
P/S
6.6
Peer P/E
33.1
Similar listed perps
Revenue estimate
$5.2B
Next fiscal year
Earnings
2026-10-29
Revenue est. $1.3B · Updated 2h ago
Dividend
-

Fundamental detail

Annual + quarterly
Latest revenue$4.7B
Net margin+17.9%
Free cash flow$1.1B
Net debt$472M
2020$1.9B
2021$2.4B
2022$2.9B
2023$3.6B
2024$4B
2025$4.7B
PeriodRevenueGrowthNet incomeFCF
2020$1.9B+31%$493.6M$276.6M
2021$2.4B+27%$216.9M$53.3M
2022$2.9B+19%$341.2M$304.7M
2023$3.6B+24%$541.5M$511.9M
2024$4B+11%$576.2M$630.7M
2025$4.7B+16%$836.3M$1.1B
PeriodGross marginOperating marginNet marginROEROA
2020+66.4%+15.5%+25.6%+27.0%+11.5%
2021+68.6%+10.9%+8.9%+10.6%+4.4%
2022+64.7%+13.4%+11.7%+16.0%+6.3%
2023+63.2%+16.5%+14.9%+26.2%+8.6%
2024+60.5%+14.9%+14.3%+27.4%+8.9%
2025+60.1%+19.6%+17.9%+30.5%+13.2%
PeriodCashDebtNet debtCurrent ratio
2020$817.6M$1.8B$1B5.58
2021$1.1B$2.2B$1.1B5.11
2022$642.3M$2.1B$1.5B1.99
2023$566.3M$2.6B$2B2.84
2024$606.1M$2.6B$2B1.47
2025$917.7M$1.4B$472M1.88
PeriodMarket capEnterprise valueP/SP/E
2020$34.9B$35.9B18.170.6
2021$51.9B$53B21.2239.7
2022$44.1B$45.6B15.2128.7
2023$47.9B$49.9B13.286.2
2024$31.5B$33.4B7.853.3
2025$25.9B$26.4B5.631.0
Q3 2024$994.2M
Q4 2024$1.1B
Q1 2025$1B
Q2 2025$1.2B
Q3 2025$1.2B
Q4 2025$1.3B
Q1 2026$1.2B
Q2 2026$1.3B
PeriodRevenueGrowthNet incomeFCF
Q3 2024$994.2M+2%$134.6M$88.3M
Q4 2024$1.1B+8%$151.7M$176.8M
Q1 2025$1B+12%$105.4M$96.8M
Q2 2025$1.2B+15%$179.8M$208.9M
Q3 2025$1.2B+22%$283.8M$579.4M
Q4 2025$1.3B+13%$267.3M$192.1M
Q1 2026$1.2B+15%$199.5M$449M
Q2 2026$1.3B+13%$249.1M$184.5M
PeriodGross marginOperating marginNet marginROEROA
Q3 2024+59.7%+15.3%+13.5%+6.8%+2.1%
Q4 2024+58.9%+17.0%+13.6%+7.2%+2.3%
Q1 2025+56.9%+12.9%+10.2%+4.7%+1.6%
Q2 2025+59.5%+18.4%+15.5%+7.0%+2.5%
Q3 2025+60.5%+20.1%+23.5%+10.4%+3.8%
Q4 2025+62.9%+25.6%+21.2%+9.7%+4.2%
Q1 2026+62.9%+21.4%+16.7%+6.7%+3.0%
Q2 2026+63.4%+24.3%+19.0%+9.5%+3.9%
PeriodCashDebtNet debtCurrent ratio
Q3 2024$621.2M$2.6B$2B2.46
Q4 2024$606.1M$2.6B$2B1.47
Q1 2025$904.9M$2.6B$1.7B1.50
Q2 2025$1.2B$2.6B$1.4B1.52
Q3 2025$1.8B$2.6B$739.9M1.56
Q4 2025$917.7M$1.4B$472M1.88
Q1 2026$1.1B$1.4B$266.6M1.95
Q2 2026$1.1B$1.4B$293.4M1.73
PeriodMarket capEnterprise valueP/SP/E
Q3 2024$26.4B$28.4B26.647.9
Q4 2024$31.1B$33B27.949.9
Q1 2025$26.7B$28.4B25.863.2
Q2 2025$34.2B$35.6B29.647.4
Q3 2025$26.3B$27.1B21.823.0
Q4 2025$25.7B$26.1B20.424.0
Q1 2026$24.2B$24.5B20.330.2
Q2 2026$25.8B$26.1B19.825.9

Refreshed 2h ago

Charts: revenue, profit, cash flow & valuation
Revenue$1.3BQ2 2026
$327.1M$654.2M$981.3M$1.3BQ3 2023: $975MQ4 2023: $1BQ1 2024: $921MQ2 2024: $1BQ3 2024: $994.2MQ4 2024: $1.1BQ1 2025: $1BQ2 2025: $1.2BQ3 2025: $1.2BQ4 2025: $1.3BQ1 2026: $1.2BQ2 2026: $1.3BQ3 2023Q2 2026
Net income$249.1MQ2 2026
$71M$141.9M$212.9M$283.8MQ3 2023: $120.7MQ4 2023: $256.3MQ1 2024: $146.4MQ2 2024: $143.5MQ3 2024: $134.6MQ4 2024: $151.7MQ1 2025: $105.4MQ2 2025: $179.8MQ3 2025: $283.8MQ4 2025: $267.3MQ1 2026: $199.5MQ2 2026: $249.1MQ3 2023Q2 2026
EBITDA$388.7MQ2 2026
$105.2M$210.3M$315.5M$420.6MQ3 2023: $293.5MQ4 2023: $303.6MQ1 2024: $189.6MQ2 2024: $244.7MQ3 2024: $237.4MQ4 2024: $274MQ1 2025: $219MQ2 2025: $308.8MQ3 2025: $420.6MQ4 2025: $410.1MQ1 2026: $339.7MQ2 2026: $388.7MQ3 2023Q2 2026
Free cash flow$184.5MQ2 2026
$144.9M$289.7M$434.6M$579.4MQ3 2023: $218.8MQ4 2023: $81.1MQ1 2024: $152.3MQ2 2024: $213.3MQ3 2024: $88.3MQ4 2024: $176.8MQ1 2025: $96.8MQ2 2025: $208.9MQ3 2025: $579.4MQ4 2025: $192.1MQ1 2026: $449MQ2 2026: $184.5MQ3 2023Q2 2026
EPS$0.64Q2 2026
$0.18$0.35$0.52$0.7Q3 2023: $0.29Q4 2023: $0.62Q1 2024: $0.36Q2 2024: $0.35Q3 2024: $0.34Q4 2024: $0.38Q1 2025: $0.27Q2 2025: $0.45Q3 2025: $0.7Q4 2025: $0.68Q1 2026: $0.51Q2 2026: $0.64Q3 2023Q2 2026
Cash / Debt$1.1BQ2 2026
$679.7M$1.4B$2B$2.7BQ3 2023 · Cash: $643.7MQ3 2023 · Debt: $2.7BQ4 2023 · Cash: $566.3MQ4 2023 · Debt: $2.6BQ1 2024 · Cash: $851.2MQ1 2024 · Debt: $2.6BQ2 2024 · Cash: $939.2MQ2 2024 · Debt: $2.6BQ3 2024 · Cash: $621.2MQ3 2024 · Debt: $2.6BQ4 2024 · Cash: $606.1MQ4 2024 · Debt: $2.6BQ1 2025 · Cash: $904.9MQ1 2025 · Debt: $2.6BQ2 2025 · Cash: $1.2BQ2 2025 · Debt: $2.6BQ3 2025 · Cash: $1.8BQ3 2025 · Debt: $2.6BQ4 2025 · Cash: $917.7MQ4 2025 · Debt: $1.4BQ1 2026 · Cash: $1.1BQ1 2026 · Debt: $1.4BQ2 2026 · Cash: $1.1BQ2 2026 · Debt: $1.4BQ3 2023Q2 2026
CashDebt
Profitability+63.4%Q2 2026
+16.0%+32.0%+47.9%+63.9%Q3 2023 · Gross margin: +63.9%Q4 2023 · Gross margin: +63.5%Q1 2024 · Gross margin: +61.0%Q2 2024 · Gross margin: +62.4%Q3 2024 · Gross margin: +59.7%Q4 2024 · Gross margin: +58.9%Q1 2025 · Gross margin: +56.9%Q2 2025 · Gross margin: +59.5%Q3 2025 · Gross margin: +60.5%Q4 2025 · Gross margin: +62.9%Q1 2026 · Gross margin: +62.9%Q2 2026 · Gross margin: +63.4%Q3 2023 · Operating margin: +21.1%Q4 2023 · Operating margin: +21.0%Q1 2024 · Operating margin: +11.0%Q2 2024 · Operating margin: +15.7%Q3 2024 · Operating margin: +15.3%Q4 2024 · Operating margin: +17.0%Q1 2025 · Operating margin: +12.9%Q2 2025 · Operating margin: +18.4%Q3 2025 · Operating margin: +20.1%Q4 2025 · Operating margin: +25.6%Q1 2026 · Operating margin: +21.4%Q2 2026 · Operating margin: +24.3%Q3 2023 · Net margin: +12.4%Q4 2023 · Net margin: +24.8%Q1 2024 · Net margin: +15.9%Q2 2024 · Net margin: +14.3%Q3 2024 · Net margin: +13.5%Q4 2024 · Net margin: +13.6%Q1 2025 · Net margin: +10.2%Q2 2025 · Net margin: +15.5%Q3 2025 · Net margin: +23.5%Q4 2025 · Net margin: +21.2%Q1 2026 · Net margin: +16.7%Q2 2026 · Net margin: +19.0%Q3 2023Q2 2026
Gross marginOperating marginNet margin
Revenue growth+13.1%Q2 2026
+5.4%+10.8%+16.2%+21.6%Q3 2024: +2.0%Q4 2024: +7.6%Q1 2025: +12.5%Q2 2025: +15.2%Q3 2025: +21.6%Q4 2025: +13.1%Q1 2026: +15.0%Q2 2026: +13.1%Q3 2023Q2 2026
Shares outstanding391.8MQ2 2026
106.7M213.4M320.1M426.8MQ3 2023: 426.8MQ4 2023: 415.9MQ1 2024: 416.7MQ2 2024: 416.8MQ3 2024: 410.2MQ4 2024: 406.7MQ1 2025: 407.5MQ2 2025: 408.2MQ3 2025: 407.4MQ4 2025: 398.9MQ1 2026: 393.6MQ2 2026: 391.8MQ3 2023Q2 2026
Valuation25.9Q2 2026
22.745.468.190.8Q3 2023 · P/E: 75.2Q4 2023 · P/E: 46.3Q1 2024 · P/E: 90.8Q2 2024 · P/E: 77.9Q3 2024 · P/E: 47.9Q4 2024 · P/E: 49.9Q1 2025 · P/E: 63.2Q2 2025 · P/E: 47.4Q3 2025 · P/E: 23.0Q4 2025 · P/E: 24.0Q1 2026 · P/E: 30.2Q2 2026 · P/E: 25.9Q3 2023 · P/S: 37.0Q4 2023 · P/S: 46.1Q1 2024 · P/S: 58.4Q2 2024 · P/S: 44.6Q3 2024 · P/S: 26.6Q4 2024 · P/S: 27.9Q1 2025 · P/S: 25.8Q2 2025 · P/S: 29.6Q3 2025 · P/S: 21.8Q4 2025 · P/S: 20.4Q1 2026 · P/S: 20.3Q2 2026 · P/S: 19.8Q3 2023Q2 2026
P/EP/S
Revenue$4.7B2025
$1.2B$2.3B$3.5B$4.7B2018: $1B2019: $1.5B2020: $1.9B2021: $2.4B2022: $2.9B2023: $3.6B2024: $4B2025: $4.7B20182025
Net income$836.3M2025
$113.8M$354.6M$595.5M$836.3M2018: -$127.1M2019: $101.1M2020: $493.6M2021: $216.9M2022: $341.2M2023: $541.5M2024: $576.2M2025: $836.3M20182025
EBITDA$1.4B2025
$283.6M$641.9M$1B$1.4B2018: -$74.7M2019: $213.2M2020: $376.8M2021: $377.5M2022: $565.3M2023: $916.7M2024: $945.7M2025: $1.4B20182025
Free cash flow$1.1B2025
$269.3M$538.6M$807.9M$1.1B2018: $56.1M2019: $134.5M2020: $276.6M2021: $53.3M2022: $304.7M2023: $511.9M2024: $630.7M2025: $1.1B20182025
EPS$2.092025
$0.25$0.86$1.48$2.092018: -$0.362019: $0.272020: $1.272021: $0.512022: $0.82023: $1.32024: $1.422025: $2.0920182025
Cash / Debt$917.7M2025
$648.5M$1.3B$1.9B$2.6B2018 · Cash: $1.1B2018 · Debt: $1B2019 · Cash: $446.2M2019 · Debt: $1.2B2020 · Cash: $817.6M2020 · Debt: $1.8B2021 · Cash: $1.1B2021 · Debt: $2.2B2022 · Cash: $642.3M2022 · Debt: $2.1B2023 · Cash: $566.3M2023 · Debt: $2.6B2024 · Cash: $606.1M2024 · Debt: $2.6B2025 · Cash: $917.7M2025 · Debt: $1.4B20182025
CashDebt
Profitability+60.1%2025
+3.6%+25.3%+47.0%+68.6%2018 · Gross margin: +64.4%2019 · Gross margin: +63.1%2020 · Gross margin: +66.4%2021 · Gross margin: +68.6%2022 · Gross margin: +64.7%2023 · Gross margin: +63.2%2024 · Gross margin: +60.5%2025 · Gross margin: +60.1%2018 · Operating margin: -18.1%2019 · Operating margin: +9.6%2020 · Operating margin: +15.5%2021 · Operating margin: +10.9%2022 · Operating margin: +13.4%2023 · Operating margin: +16.5%2024 · Operating margin: +14.9%2025 · Operating margin: +19.6%2018 · Net margin: -12.3%2019 · Net margin: +6.8%2020 · Net margin: +25.6%2021 · Net margin: +8.9%2022 · Net margin: +11.7%2023 · Net margin: +14.9%2024 · Net margin: +14.3%2025 · Net margin: +17.9%20182025
Gross marginOperating marginNet margin
Revenue growth+15.6%2025
+10.8%+21.5%+32.3%+43.1%2019: +43.1%2020: +30.5%2021: +27.1%2022: +18.8%2023: +24.5%2024: +11.3%2025: +15.6%20182025
Shares outstanding405.5M2025
107.2M214.4M321.6M428.8M2018: 352.8M2019: 369.2M2020: 390M2021: 428.8M2022: 427.5M2023: 425.5M2024: 412.7M2025: 405.5M20182025
Valuation31.02025
-2.578.3159.0239.72018 · P/E: -83.22019 · P/E: 195.32020 · P/E: 70.62021 · P/E: 239.72022 · P/E: 128.72023 · P/E: 86.22024 · P/E: 53.32025 · P/E: 31.02018 · P/S: 10.22019 · P/S: 13.52020 · P/S: 18.12021 · P/S: 21.22022 · P/S: 15.22023 · P/S: 13.22024 · P/S: 7.82025 · P/S: 5.620182025
P/EP/S

Next catalyst

Catalysts

Earnings
2026-10-29
Revenue est. $1.3B · Updated 2h ago

No unusual perp activity right now.

Research data

Analysts, filings and peer context

Estimates

6
DateEPS estimateRevenue estimateGrowthAnalysts
FY 20262.67$5.2B+12%15
FY 20273.12$5.8B+24%16
FY 20283.72$6.5B+38%7
FY 20294.33$7.2B+54%2
FY 20305.05$8B+71%4
Q1 20270.65$1.3B+11%6

Company events

6
2026-10-29EarningsActual - / Estimate 0.67-
2026-07-30EarningsActual 0.7 / Estimate 0.61Beat
2026-04-30EarningsActual 0.56 / Estimate 0.47Beat
2026-02-12EarningsActual 0.68 / Estimate 0.65Beat
2025-10-30EarningsActual 0.61 / Estimate 0.58Beat
2025-07-30EarningsActual 0.48 / Estimate 0.44Beat

Peer comparison

Similar listed perps

Analyst track record

How the analysts covering DXCM have done: ratings, price-target accuracy and the measured reaction after their calls.

12 months3 years
Ratings156453
Analysts3336
Buy / hold / sell142 / 11 / 3410 / 40 / 3
Upgrades / downgrades / initiations1 / 0 / 44 / 3 / 11
Price targets hit / missed84 / 56 (60%)108 / 311 (26%)
Avg. return after a rating (TipRanks)+0.9%-13.0%
Best / worst call+37.5% / -22.7%+37.5% / -49.1%

After buy calls on this stock: median 21-day move +2.2% vs S&P 500 +1.2% (n = 409)

Most accurate on this stock

Share of an analyst's price targets on this stock that the price reached within 12 months (our measurement over the last 3 years, at least 8 targets). It describes past calls, not the odds of the current one.

  1. William PlovanicCanaccord Genuity47% hit rate on this stock · 17 targets measuredBuytarget $90.00Aug 3, 2026
  2. Mike KratkyLeerink Partners44% hit rate on this stock · 18 targets measuredBuytarget $84.00Oct 14, 2025
  3. Travis SteedBank of America Securities43% hit rate on this stock · 14 targets measuredBuyno targetJul 31, 2026

Latest ratings

DateAnalystCallTarget
Sep 23, 2026Richard NewitterTruist FinancialBuyMaintained$102
Sep 18, 2026Richard NewitterTruist FinancialBuyReiterated$102
Sep 18, 2026Josh JenningsTD CowenBuyMaintained$95.00
Sep 9, 2026Larry BiegelsenWells FargoBuyMaintained$90.00
Aug 14, 2026Joanne WuenschCitiBuyMaintained$105
Consensus over the last 12 months buy hold sell avg. target month-end close
Monthly buy, hold and sell shares of analyst ratings with the average price target and the month-end close$60.00$65.00$70.00$75.00$80.00$85.00$90.00Oct 25 · Buy 21 · Hold 4 · Sell 0Oct 25Nov 25 · Buy 21 · Hold 5 · Sell 0Dec 25 · Buy 22 · Hold 4 · Sell 0Dec 25Jan 26 · Buy 20 · Hold 3 · Sell 1Feb 26 · Buy 20 · Hold 3 · Sell 1Feb 26Mar 26 · Buy 19 · Hold 3 · Sell 1Apr 26 · Buy 19 · Hold 3 · Sell 1Apr 26May 26 · Buy 24 · Hold 2 · Sell 1Jun 26 · Buy 25 · Hold 2 · Sell 1Jun 26Jul 26 · Buy 27 · Hold 2 · Sell 1Aug 26 · Buy 26 · Hold 1 · Sell 1Aug 26Sep 26 · Buy 26 · Hold 1 · Sell 1Oct 25 · avg. target $91.14Nov 25 · avg. target $85.96Dec 25 · avg. target $85.61Jan 26 · avg. target $84.26Feb 26 · avg. target $86.10Mar 26 · avg. target $85.85Apr 26 · avg. target $85.40May 26 · avg. target $82.39Jun 26 · avg. target $84.13Jul 26 · avg. target $90.46Aug 26 · avg. target $90.81Sep 26 · avg. target $91.15Oct 25 · month-end close $58.22Nov 25 · month-end close $63.47Dec 25 · month-end close $66.37Jan 26 · month-end close $73.04Feb 26 · month-end close $73.43Mar 26 · month-end close $62.80Apr 26 · month-end close $59.55May 26 · month-end close $73.74Jun 26 · month-end close $67.35Jul 26 · month-end close $83.45Aug 26 · month-end close $91.06Sep 26 · month-end close $86.62

Share of analysts per call each month (latest call per analyst within 180 days). Targets and closes in USD.

TipRanks data via FMP · computed Sep 27, 2026 · 156 ratings

Embed this asset

DXCM perpetuals · perpequities.comDXCM perpetuals · perpequities.com
<a href="https://perpequities.com/stocks/dxcm-perp"><img src="https://perpequities.com/badge/dxcm-perp.svg" width="240" height="64" alt="DXCM perpetuals · perpequities.com" loading="lazy"></a>

Next step

Stay on top of DXCM perps

Signals with a track record

Analysts who hit 70%+ of their targets on the perps we track, congress buys over $500k, 13F positions over $5M, funding spreads that have paid for days. Every post shows the evidence. Free, no sign-up.

Join on Telegram

Weekly digest by email

The listings, funding and moves that matter for DXCM — one email every Sunday.

Watchlist and alerts

Price and funding alerts for DXCM, via push or Telegram.

Set an alert

Follow the live feed

Daily movers, new listings and funding extremes as they happen.

Follow on X